Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
61-75 of 2230 results
Neovacs partners with 3P Biopharmaceuticals to manufacture interferon alpha cytokine
Neovacs has partnered with 3P Biopharmaceuticals to manufacture interferon alpha (IFNα) cytokine.
Production & Manufacturing > Manufacturing > News
Sun Pharma to buy 85% stake in Russian pharmaceutical firm Biosintez
Sun Pharma has agreed to acquire 85.1% stake in JSC Biosintez, a Russian pharmaceutical firm engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region.
Production & Manufacturing > Manufacturing > News
Novartis acquires Selexys Pharmaceuticals in $665m deal
By PBR Staff Writer
Novartis has acquired Selexys Pharmaceuticals, an Oklahoma City based company specializing in hematologic and inflammatory disorders, in a deal worth about $665m.
Production & Manufacturing > Manufacturing > News
IV-administered Ganaxolone and Diazepam synergistically block seizures in animal model of SE
Marinus Pharmaceuticals presented preclinical data showing that the combination of its CNS-selective GABAA modulator ganaxolone and diazepam administered intravenously (IV) produced a synergistic effect in blocking pilocarpine-induced seizures in a benzodiazepine refractory model of status epilepticus (SE).
Production & Manufacturing > Manufacturing > News
Biocon, Mylan seek FDA approval for trastuzumab biosimilar
By PBR Staff Writer
Drug makers Biocon and Mylan are seeking approval from the US Food and Drug Administration (USFDA) for a biosimilar version of Roche’s cancer drug trastuzumab.
Production & Manufacturing > Manufacturing > News
FDA gives priority review status to Novartis’ breast cancer drug
By PBR Staff Writer
Pharma giant Novartis has secured the US Food and Drug Administration (FDA) Priority Review for its advanced breast cancer drug ribociclib (LEE011).
Production & Manufacturing > Manufacturing > News
Portola expands collaboration with Daiichi to develop AndexXa in Germany
Portola Pharmaceuticals (PTLA) has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop AndexXa (andexanet alfa) as an antidote for the former’s Factor Xa inhibitor named as edoxaban.
Production & Manufacturing > Manufacturing > News
Nimbus secures $200m from Gilead for inhibitor program acquisition
Nimbus Therapeutics secured a $200m from Gilead Sciences in a payment related to the latter’s allosteric Acetyl-CoA Carboxylase (ACC) inhibitor program with NDI-010976 (now GS-0976) which was previously acquired from Nimbus.
Production & Manufacturing > Manufacturing > News
Celgene and IBM Watson to develop new offering for patient safety monitoring
Celgene and IBM Watson Health will co-develop a new offering that aims to enhance pharmacovigilance methods used to collect, assess, monitor, and report adverse drug reactions.
Production & Manufacturing > Manufacturing > News
Valeant in talks to divest gastroenterology business unit
By PBR Staff Writer
Valeant Pharmaceuticals International is in talks with third parties to divest its various assets, including Salix gastroenterology business unit.
Production & Manufacturing > Manufacturing > News
FDA delays approval of Sanofi and Regeneron's rheumatoid arthritis drug sarilumab
By PBR Staff Writer
The US Food and Drug Administration (FDA) has delayed approval for Sanofi and Regeneron Pharmaceuticals' experimental treatment for rheumatoid arthritis (RA) due to manufacturing deficiencies.
Production & Manufacturing > Manufacturing > News
FDA accepts for priority review Bristol-Myers' sBLA for Opdivo for urothelial carcinoma use
The US Food and Drug Administration (FDA) has accepted for priority review Bristol-Myers Squibb's supplemental biologics license application (sBLA) for Opdivo (nivolumab) in previously treated patients With advanced form of bladder cancer.
Production & Manufacturing > Manufacturing > News
Virtus sues FDA for clearing potassium chloride market of competition
Virtus Pharmaceuticals has filed a lawsuit against the US Food and Drug Administration (FDA) and Department of Health and Human Services (HHS), seeking to prevent a monopoly, and potential price hikes, in the marketplace for potassium chloride products.
Production & Manufacturing > Manufacturing > News
VBL Therapeutics unveils plans to build new manufacturing facility in Israel
VBL Therapeutics has entered in to a long-term lease contract for a new stand-alone facility in Modiin, Israel.
Production & Manufacturing > Manufacturing > News
Merck opens biopharmaceutical support center in Korea
By PBR Staff Writer
German life sciences firm Merck has opened a new biopharmaceuticals production and development support center in the Songdo district of Incheon, Korea.
Production & Manufacturing > Manufacturing > News
61-75 of 2230 results